Drug Approval | May 26, 2022
Eugia Pharma receives USFDA approval for Pemetrexed
Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry
This Keytruda combination is the first immunotherapy option approved in the EU for high-risk early-stage TNBC
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
Acute asthma attack is a common cause of admission to emergency departments (EDs) among children, and triage by severity is important for determining appropriate clinical treatment
Includes thermostabilized Ebola vaccines
A total of five observations for Goa and 17 for Monroe
Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; approval granted more than two months ahead of USFDA’s Priority Review action date
Subscribe To Our Newsletter & Stay Updated
